Medical use of ras antagonists for the treatment of capillary malformation
CA 2515519 A1 · Owner: Universite Catholique De Louvain · Inventors: Boon, Laurence; Eerola, Iiro; Vikkula, Miikka
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to the field of vascular anomalies and methods for diagnosing and treating them. The invention provides for the causative gene (RASA1) and mutations therein which are useful for diagnosing inherited capillary malformations. The invention further provides RASA1 antagonists for use in treatment of capillary malformations.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 20, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 20, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 20, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.